Circulation device company requests CAD (coronary artery disease) coverage
This article was originally published in Clinica
The Health Care Financing Administration (HCFA) is considering whether to expand the scope of Medicare's coverage of external counterpulsation (ECP), a noninvasive therapy which is used to treat coronary artery disease (CAD). Medicare, the federal health plan for the elderly and disabled, currently covers ECP only to treat certain patients with stable angina pectoris.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.